Clinical and Spectrophotometric Evaluation of Skin Photoadaptation in Vitiligo Patients after a Short Cycle of NB-UVB Phototherapy.


Journal

Dermatology (Basel, Switzerland)
ISSN: 1421-9832
Titre abrégé: Dermatology
Pays: Switzerland
ID NLM: 9203244

Informations de publication

Date de publication:
2019
Historique:
received: 07 11 2018
accepted: 07 08 2019
pubmed: 7 10 2019
medline: 16 4 2020
entrez: 7 10 2019
Statut: ppublish

Résumé

The phenomenon of photoadaptation to narrow-band ultraviolet B (NB-UVB) radiation has been previously described in vitiligo and has usually been clinically measured by the assessment of the minimal erythema dose (MED) after phototesting. To assess the photoadaptive response in vitiligo and healthy skin after NB-UVB phototherapy not only clinically, but also by spectrophotometry. Fourteen patients affected by generalized vitiligo underwent NB-UVB phototherapy twice weekly for 12 weeks. Before and after phototherapy, a phototesting procedure was administered on vitiligo patches and adjacent healthy skin with a solar simulated radiation (SSR). Visual assessment of the MED took place after 24 h. A spectrophotometer was used to assess the a* value and the melanin index (MI*), as signs of skin erythema and pigmentation. The photoadaptation factor (MED-PF) and the a* photoadaptation factor (a*-PF) were calculated. After NB-UVB phototherapy, both vitiligo and healthy skin showed an increase in MED and MI* values and a reduction of skin erythema compared to baseline (p < 0.05). MED-PF data showed a photoadaptation in 10 (71.4%) vitiligo lesions and in 12 (85.7%) healthy skin areas. The assessment of the a*-PF showed a negative mean percentage value in all affected and unaffected skin areas. A short cycle of NB-UVB phototherapy can induce photoadaptation in vitiligo by increasing the MED and reducing skin erythema after stimulation with SSR. This is most likely due to the physical filter function induced by ultraviolet radiation.

Sections du résumé

BACKGROUND BACKGROUND
The phenomenon of photoadaptation to narrow-band ultraviolet B (NB-UVB) radiation has been previously described in vitiligo and has usually been clinically measured by the assessment of the minimal erythema dose (MED) after phototesting.
OBJECTIVES OBJECTIVE
To assess the photoadaptive response in vitiligo and healthy skin after NB-UVB phototherapy not only clinically, but also by spectrophotometry.
MATERIALS AND METHODS METHODS
Fourteen patients affected by generalized vitiligo underwent NB-UVB phototherapy twice weekly for 12 weeks. Before and after phototherapy, a phototesting procedure was administered on vitiligo patches and adjacent healthy skin with a solar simulated radiation (SSR). Visual assessment of the MED took place after 24 h. A spectrophotometer was used to assess the a* value and the melanin index (MI*), as signs of skin erythema and pigmentation. The photoadaptation factor (MED-PF) and the a* photoadaptation factor (a*-PF) were calculated.
RESULTS RESULTS
After NB-UVB phototherapy, both vitiligo and healthy skin showed an increase in MED and MI* values and a reduction of skin erythema compared to baseline (p < 0.05). MED-PF data showed a photoadaptation in 10 (71.4%) vitiligo lesions and in 12 (85.7%) healthy skin areas. The assessment of the a*-PF showed a negative mean percentage value in all affected and unaffected skin areas.
CONCLUSIONS CONCLUSIONS
A short cycle of NB-UVB phototherapy can induce photoadaptation in vitiligo by increasing the MED and reducing skin erythema after stimulation with SSR. This is most likely due to the physical filter function induced by ultraviolet radiation.

Identifiants

pubmed: 31586997
pii: 000502853
doi: 10.1159/000502853
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

509-515

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Mariachiara Arisi (M)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy, mariachiara.arisi@gmail.com.

Maria Teresa Rossi (MT)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Marta Fusano (M)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Alessandra Gualini (A)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Cesare Tomasi (C)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Occupational Health, University of Brescia, Brescia, Italy.

Erica Moggio (E)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Simone Caravello (S)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Piergiacomo Calzavara-Pinton (P)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Marina Venturini (M)

Dermatology Department, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH